HOCHTIEF Aktiengesellschaft

  • WKN: 607000
  • ISIN: DE0006070006
  • Land: Deutschland

Nachricht vom 29.07.2020 | 01:08

HOCHTIEF Aktiengesellschaft: CIMIC in exclusive negotiations for Thiess equity partner

HOCHTIEF Aktiengesellschaft / Key word(s): Disposal
HOCHTIEF Aktiengesellschaft: CIMIC in exclusive negotiations for Thiess equity partner

29-Jul-2020 / 01:08 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


CIMIC Group, in which HOCHTIEF holds a 77.1% stake, today announced that it has signed an exclusivity agreement and is in advanced negotiations with funds advised by Elliott Advisors (UK) Limited (together Elliott) regarding the potential investment by Elliott into 50% of the share capital of Thiess, the world's largest mining services provider, which would provide joint control of Thiess to CIMIC and Elliott.

The introduction of an equity partner into Thiess would capitalise on the robust outlook for the mining sector and provide capital for Thiess' continued growth, while enabling CIMIC to maintain its strong balance sheet.

CIMIC expects that the advanced negotiations will conclude in the coming weeks with a share purchase agreement that will be subject to the customary conditions including all regulatory approvals.

 

29-Jul-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

Solutiance: Hohe Wachstumsdynamik durch den Ausbau des Plattformgeschäfts erwartet

Im ersten Halbjahr 2020 konnte Solutiance den eingeschlagenen Wachstumskurs fortsetzen und im Rahmen dessen die Gesamtleistung (Umsatz zzgl. Bestandsveränderungen) um rund 75 % auf 0,66 Mio. € (1. HJ 2019: 0,38 Mio. €) erhöhen. Das Unternehmen erwartet für das Gesamtjahr durch den weiteren Ausbau der softwarebasierten Dienstleistungen einen Umsatzsprung im Vergleich zum Vorjahr auf rund 3 Mio. €. Bei einem von uns ermittelten Kursziel von 4,85 € vergeben wir das Rating KAUFEN.

Aktuelle Research-Studie

Formycon AG

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Kaufen

24. September 2020